Michael Baseler spends much of his time researching Immunology, Virology, Virus, Viral load and Acquired immunodeficiency syndrome. His work carried out in the field of Immunology brings together such families of science as Clinical trial and Bromodeoxyuridine. He interconnects Cytotoxic T cell, Interleukin 21, T lymphocyte and Asymptomatic in the investigation of issues within Virology.
Michael Baseler combines subjects such as Lymphocyte and Immunopathology with his study of Virus. His biological study spans a wide range of topics, including CD8 and Viral replication. His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Ex vivo, Cell growth, Chemotherapy, Pathogenesis and Viral disease.
His primary scientific interests are in Immunology, Virology, Virus, Cytotoxic T cell and Molecular biology. His Immunology study frequently draws connections to other fields, such as Peripheral blood mononuclear cell. His study in the field of Viral load and Viral replication also crosses realms of Population.
His Virus course of study focuses on Lymphocyte and Clinical trial. His research in Molecular biology tackles topics such as Cytotoxicity which are related to areas like Effector. Michael Baseler studied Viral disease and Acquired immunodeficiency syndrome that intersect with Immunopathology and Herpesviridae.
Immunology, Molecular biology, Cytotoxic T cell, Cytokine and Peripheral blood mononuclear cell are his primary areas of study. His is doing research in Flow cytometry, Pathogenesis, Viral load, C-reactive protein and Interleukin 21, both of which are found in Immunology. His Molecular biology research incorporates themes from Transfection and Cell biology.
Michael Baseler focuses mostly in the field of Cytotoxic T cell, narrowing it down to topics relating to T cell and, in certain cases, Cell growth, Virus, Interleukin 2, Interleukin 15 and Viremia. Michael Baseler has researched Cytokine in several fields, including Viability assay, Biological pathway, Gene expression and Viral replication. His Peripheral blood mononuclear cell study incorporates themes from Gene expression profiling, Granzyme B, Cytotoxicity, Lymphocyte and Effector.
Michael Baseler mainly focuses on Molecular biology, Response element, Reporter gene, Transfection and DNA. His research in Molecular biology intersects with topics in microRNA, Gene, Viral replication, Cell biology and Interleukin. His Response element investigation overlaps with other areas such as Ku80, Ku70 and Mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Tae-Wook Chun;Lieven Stuyver;Stephanie B. Mizell;Linda A. Ehler.
Proceedings of the National Academy of Sciences of the United States of America (1997)
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
Da-Wei Huang;Brad T. Sherman;Qina Tan;Jack R Collins.
Genome Biology (2007)
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
Da Wei Huang;Brad T. Sherman;Qina Tan;Joseph Kir.
Nucleic Acids Research (2007)
DAVID-WS
Xiaoli Jiao;Brad T. Sherman;Da Wei Huang;Robert Stephens.
Bioinformatics (2012)
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun.
Proceedings of the National Academy of Sciences of the United States of America (1999)
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
SM Schnittman;MC Psallidopoulos;HC Lane;L Thompson.
Science (1989)
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
H Masur;F P Ognibene;R Yarchoan;J H Shelhamer.
Annals of Internal Medicine (1989)
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.
M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche.
Nature Medicine (1997)
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.
S M Schnittman;H C Lane;J Greenhouse;J S Justement.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.
Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon.
The New England Journal of Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Leidos (United States)
National Institute of Allergy and Infectious Diseases
National Institutes of Health
National Institute of Allergy and Infectious Diseases
National Institutes of Health
National Institute of Allergy and Infectious Diseases
University of Science and Technology of China
National Yang Ming Chiao Tung University
École Centrale de Nantes
University College Dublin
National Chemical Laboratory
Changsha University of Science and Technology
Colorado School of Mines
Seattle Children's Hospital
University of Melbourne
ETH Zurich
University of California, Davis
Children's Hospital of Philadelphia
National Autonomous University of Mexico
University of Antwerp
Missouri University of Science and Technology
University of Southern Denmark